GlassScriptPhysician profile
Kevin W Windom
NPI 1821048653
$2,916.37
in general payments reported to CMS, 2019-2025
33 companies · $504 in 2025
The $504 reported for 2025 was more than what 81% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $459 · 2020: $176 · 2021: $262 · 2022: $445 · 2023: $422 · 2024: $647 · 2025: $504.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,574.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,573.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $476.25 | 2019-2025 | Lo Loestrin Fe, Liletta |
| Mayne Pharma Commercial LLC | $379.26 | 2021-2025 | |
| Intuitive Surgical, INC. | $259.61 | 2020-2024 | Da Vinci Surgical System |
| Astellas Pharma US INC | $241.88 | 2019-2025 | Veozah |
| Revance Therapeutics, INC. | $206.56 | 2024 | Daxxify |
| Bayer Healthcare Pharmaceuticals INC. | $148.36 | 2019-2025 | |
| Organon LLC | $121.71 | 2022-2025 | Nexplanon |
| Medtronic, INC. | $115.41 | 2025 | |
| Escala Medical INC. | $94.42 | 2024 | |
| Exeltis, USA INC. | $83.62 | 2023-2025 | Slynd |
| Boston Scientific Corporation | $83.59 | 2019-2024 | Obtryx System - Curved |
| Davol INC. | $73.35 | 2019-2025 | Arista |
| Daiichi Sankyo INC. | $51.24 | 2019 | |
| Avion Pharmaceuticals | $49.84 | 2019-2023 | NP Thyroid 60 |
| Evofem Biosciences, INC. | $48.33 | 2021-2023 | Phexxi |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $47.31 | 2025 | Arista |
| Sumitomo Pharma America, INC. | $46.80 | 2023-2025 | Gemtesa, Myfembree |
| Therapeuticsmd, INC. | $46.02 | 2019-2022 | |
| Pfizer INC. | $37.94 | 2019-2020 | |
| Meditrina | $36.68 | 2022-2023 | |
| Vertical Pharmaceuticals, LLC | $30.64 | 2019 | |
| Stryker Corporation | $30.38 | 2020 | |
| Ascend Therapeutics US, LLC | $28.92 | 2020-2024 | |
| Duchesnay USA Incorporated | $28.47 | 2019 | |
| Conmed Corporation | $24.94 | 2019-2024 | Airseal |
| Millicent US INC | $21.48 | 2020 | |
| Hologic Sales and Service, LLC | $19.16 | 2025 | Myosure Tissue Removal Device, Novasure |
| Axonics, INC. | $17.47 | 2023 | Axonics, Bulkamid |
| Merck Sharp & Dohme LLC | $17.39 | 2023 | |
| Kci USA, INC. | $14.16 | 2023 | Prevena |
| Cumberland Pharmaceuticals, INC. | $13.85 | 2023 | Caldolor |
| Coopersurgical, INC. | $12.21 | 2022 | |
| Channel Medsystems, INC. | $9.12 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Windom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.